{
  "docId": "019de071-a0aa-74fc-b780-f72cc7f02158",
  "docSlug": "6af314fff9e6eaaf966098f4c73a6229",
  "documentTitle": "Mink Therapeutics | IPO Presentation Deck | 36 slides",
  "authorId": "mink-therapeutics",
  "authorName": "MiNK Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7860465,
  "pageNumber": 14,
  "pageCount": 36,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-a0aa-74fc-b780-f72cc7f02158/14",
  "deckHref": "/decks/019de071-a0aa-74fc-b780-f72cc7f02158",
  "deckJsonHref": "/decks/019de071-a0aa-74fc-b780-f72cc7f02158.json",
  "deckAnchorHref": "/decks/019de071-a0aa-74fc-b780-f72cc7f02158#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.84,
        "x": 0.08,
        "y": 0.81
      },
      "kind": "callout",
      "text": "Multiple Near Term Milestones and Clinical Readouts and Development Opportunities",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c09de49b-19e6-420a-81a7-1c167bc86280",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.35,
        "x": 0.04,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "1. IND submission pending 2. In the process of expanding trial into ARDS secondary to influenza",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "38daa46f-a673-46d9-8c77-8e393d8d486d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.58,
        "w": 0.92,
        "x": 0.04,
        "y": 0.21
      },
      "kind": "table",
      "text": "Therapeutic Area, Indication, Next Milestone, Planned, What is Next? Oncology, Solid Tumors, Phase 1 top-line readouts, H1 2022, Accelerated development... r/r Multiple Myeloma, Phase 1 top-line readouts, Q4 2021, Robust efficacy... Immune Mediated Diseases, GvHD, IND clearance, Q4 2021, Accelerated development... ARDS, Phase 1 top-line readouts, Q4 2021, Phase 2 expansion...",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7ab1af92-3249-4e58-917e-f3134f6937ca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.74,
        "x": 0.13,
        "y": 0.05
      },
      "kind": "title",
      "text": "AGENT-797 (iNKT Cells) Clinical Development Milestones and Plans",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e31da41c-1c78-4c05-a370-3cbe81d204f9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "f56ee090-bc95-4478-8862-62d89e2c5455",
      "evidence": "table/data: Therapeutic Area, Indication, Next Milestone, Planned, What is Next?",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 36,
      "from": 5,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "ff1f25c5-6e00-4a50-9457-841955937c0b",
      "evidence": "The document presents the why, what, and how of MiNK's iNKT cell therapies throughout the deck.",
      "position": 0,
      "objective": "Why MiNK Therapeutics' iNKT cell therapies are needed and how they work",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    },
    {
      "to": 34,
      "from": 14,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "1930f29c-63d8-4add-8285-7c1514ed675c",
      "evidence": "The document outlines multiple near-term milestones and clinical readouts.",
      "position": 1,
      "objective": "Highlighting near-term milestones and clinical readouts as a quick win and a big bet on iNKT cell therapies",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}